However, the difference in the percentage of NKT cells (CD45+CD3+CD56+) and T cells (CD45+CD3+CD56−) was insignificant between patients with lung cancer and healthy controls (Yin et al., 2021). This evidence concerns the gene NCAM1 and lung cancer.